Výsledky vyhledávání - "E, Spremulli"

Preoperative docetaxel and gemcitabine in resectable non-small cell lung cancer: A phase II trial of the Minnie Pearl Cancer Research Network

Autor: E. Vazquez, Dianna Shipley, David R. Spigel, D. A. Yardley, E. Spremulli, Joan B. Erland, H. A. Burris, D. S. Thompson, F. A. Greco, John D. Hainsworth

Publikováno v: Journal of Clinical Oncology. 25:18100-18100

18100 Background: Preoperative chemotherapy may improve outcomes for patients (pts) with resectable non-small cell lung cancer (NSCLC) compared with surgery alone. This multicenter community-based phase II trial examined the role of preoperative gemc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cadf1986ee0156b9e28afcfdd87e7b66
https://doi.org/10.1200/jco.2007.25.18_suppl.18100

Zobrazit plný text záznamu

Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized prospective phase II trial

Autor: Joan B. Erland, F. A. Greco, D. S. Thompson, G. Joseph, John D. Hainsworth, Steven W. Corso, Lisa H. Morrissey, E. Spremulli, H. A. Burris

Publikováno v: Journal of Clinical Oncology. 22:7205-7205

7205 Background: Platinum plus etoposide chemotherapy is currently standard for patients (pts) with extensive stage small cell lung cancer. Nonplatinum doublets of active newer drugs may be superior. Methods: The purpose of this randomized phase II t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b1cb6614e33300924e1d84ea872c9b1a
https://doi.org/10.1200/jco.2004.22.90140.7205

Zobrazit plný text záznamu

Chemotherapy of malignant mesothelioma

Autor: T. Hardy, Galen L. Wampler, W. Regelson, E. Spremulli, D. Borochovitz

Publikováno v: Cancer. 40:2038-2045

Twenty-three patients with malignant mesothelioma are described as to mode of presentation, symptoms, method of diagnosis and histology. Beginning in 1972, 10 patients were treated with drug combinations including Adriamycin, Dacarbazine (DTIC), Cyto

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d8deeefd50834a49b5165509cd66b5e
https://doi.org/10.1002/1097-0142(197711)40:5<2038::aid-cncr2820400507>3.0.co

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

Autor: D M, Goldenberg, E E, Kim, F, Deland, E, Spremulli, M O, Nelson, J P, Gockerman, F J, Primus, R L, Corgan, E, Alpert

Publikováno v: Cancer. 45(10)

This study reports the use of radiolabeled antibodies to alpha-fetoprotein for the detection and localization of hepatocellular and germ cell carcinomas. Twelve patients with histories of histologically-confirmed neoplasia received a total dose betwe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b65a61f477494d6fba868e6e210c15ac
https://pubmed.ncbi.nlm.nih.gov/6155193

Zobrazit plný text záznamu

Clinical study of hydrazine sulfate in advanced cancer patients

Autor: E. Spremulli, W. Regelson, Galen L. Wampler

Publikováno v: Cancer Chemotherapy and Pharmacology. 3

Twenty-five patients with a variety of solid tumors were treated with hydrazine sulfate. Hydrazine was given orally in the form of 60 mg capsules from one to four times daily. No patient had a 50% reduction of tumor size. Subjective benefit was seen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3529b399a8c25b381009bd05e59de914
https://doi.org/10.1007/bf00254983

Zobrazit plný text záznamu

2'-Deoxycoformycin-induced hemolysis in the mouse

Autor: E, Spremulli, G W, Crabtree, D L, Dexter, I, Diamond, P, Calabresi

Publikováno v: Journal of the National Cancer Institute. 68(6)

2'-Deoxycoformycin (dCF), a tight-binding inhibitor of adenosine deaminase, has recently been entered into clinical trials. Toxicity has included lymphopenia, seizures, coma, conjunctivitis, renal failure, and hemolysis. Mice treated with dCF on a va

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8f32bad6619c4e91391e15bb04179892
https://pubmed.ncbi.nlm.nih.gov/6979651

Zobrazit plný text záznamu

Chemotherapy of malignant mesothelioma

Autor: E, Spremulli, G, Wampler, W, Regelson, D, Borochovitz, T, Hardy

Publikováno v: Cancer. 40(5)

Twenty-three patients with malignant mesothelioma are described as to mode of presentation, symptoms, method of diagnosis and histology, Beginning in 1972, 10 patients were treated with drug combination including Adriamycin, Dacarbazine (DTIC), Cytox

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6e6ed36e686ef79d695d4985b9ae98ec
https://pubmed.ncbi.nlm.nih.gov/336176

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání